Entry |
|
Name |
Bictegravir (USAN/INN) |
Formula |
C21H18F3N3O5
|
Exact mass |
449.1199
|
Mol weight |
449.3799
|
Structure |

|
Simcomp |
|
Class |
|
Remark |
Product (mixture): | D11039<JP/US> |
|
Efficacy |
Antiviral, HIV integrase inhibitor |
Comment |
Treatment of HIV-1 infection
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG03135 HIV integrase inhibitor
DG02404 Bictegravir
D10909 Bictegravir
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV integrase inhibitor
D10909 Bictegravir (USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG03135 HIV integrase inhibitor
DG02404 Bictegravir
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 32
1 C8y C 17.0517 -11.1812
2 N4y N 17.0517 -9.7778
3 C8x C 18.2447 -9.0760
4 C8y C 19.5078 -9.7778
5 C8y C 19.5078 -11.1812
6 C8y C 18.2447 -11.8829
7 C5x C 15.8588 -11.8829
8 N1y N 14.5957 -11.1812
9 C1y C 14.5957 -9.7778
10 C1x C 15.8588 -9.0760
11 C1y C 13.4028 -11.8829
12 C1x C 12.2099 -11.1812
13 C1y C 12.2099 -9.7778
14 O2x O 13.4028 -9.0760
15 O5x O 15.8588 -13.2864
16 O1a O 18.2447 -13.2864
17 O5x O 20.7007 -11.8829
18 C5a C 20.7007 -9.0760
19 N1b N 21.8936 -9.7778
20 O5a O 20.7007 -7.6726
21 C1b C 23.0865 -9.0760
22 C8y C 24.2794 -9.7778
23 C8y C 25.4724 -9.0760
24 C8x C 26.7355 -9.7778
25 C8y C 26.7355 -11.1812
26 C8x C 25.5425 -11.8829
27 C8y C 24.2794 -11.1812
28 X F 23.0865 -11.8829
29 X F 27.9284 -11.8829
30 C1x C 10.9975 -10.4778
31 C1x C 12.1904 -12.5829
32 X F 25.4724 -7.6760
BOND 36
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 1 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 2 10 1
12 8 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 9 14 1
17 7 15 2
18 6 16 1
19 5 17 2
20 4 18 1
21 18 19 1
22 18 20 2
23 19 21 1
24 21 22 1
25 22 23 2
26 23 24 1
27 24 25 2
28 25 26 1
29 26 27 2
30 22 27 1
31 27 28 1
32 25 29 1
33 13 30 1 #Up
34 11 31 1 #Up
35 30 31 1
36 23 32 1
|